ZOmeta-Femara Adjuvant Synergy Trial

Trial Profile

ZOmeta-Femara Adjuvant Synergy Trial

Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2012

At a glance

  • Drugs Zoledronic acid (Primary) ; Letrozole
  • Indications Early breast cancer; Osteoporosis
  • Focus Therapeutic Use
  • Acronyms ZO-FAST
  • Sponsors Novartis; Novartis Pharmaceuticals
  • Most Recent Events

    • 10 Dec 2011 Results presented at the 34th Annual San Antonio Breast Cancer Symposium.
    • 02 Dec 2011 Five-year follow-up data on long-term overall survival outcomes will be presented at the 34th Annual San Antonio Breast Cancer Symposium, according to a Novartis media release.
    • 24 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top